MedTrace Logo

Bright Light Therapy as Augmentation of Depressive Symptoms on Acute Psychiatric Floor

NCT04385394 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-10-28

No results posted yet for this study

Summary

The purpose of this study is to explore if Bright Light Therapy (BLT) as augmentation of depression treatment on an acute psychiatric floor is feasible, helps alleviate depressive symptoms, improve functioning, and decrease length of stay on the psychiatric floor.

Conditions

Sponsors & Collaborators

  • State University of New York - Upstate Medical University

    lead OTHER

Principal Investigators

  • Luba Leontieva, MD, PhD · State University of New York - Upstate Medical University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-30
Primary Completion
2020-08-20
Completion
2020-08-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04385394 on ClinicalTrials.gov